NIH Hospital Board Announces Routine Hybrid Public Meeting
Published Date: 6/8/2026
Notice
Summary
The NIH Clinical Center Research Hospital Board is holding a hybrid meeting on October 16, 2026, open to the public both in-person and online. This meeting will share important updates from NIH leaders and discuss the hospital’s priorities, giving everyone a chance to stay informed and involved. If you want to join or send comments, make sure to check security rules and reach out ahead of time!
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11390 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding to advance science. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-11357 — National Library of Medicine; Notice of Partially Closed Meeting
The National Library of Medicine’s Board of Regents will hold a virtual meeting on July 16, 2026, with some parts open to the public and others closed to protect private info and trade secrets. This meeting affects researchers and grant applicants, as grant reviews will happen behind closed doors. Anyone can watch the open sessions online and send comments up to 15 days before the meeting—no registration needed!
2026-11367 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting science projects. If you’re involved in cell biology, heart disease, mental health, or cancer research, these reviews could impact your funding timeline and opportunities.
2026-11018 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late June and early July 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which scientific projects get funding. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10813 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health just announced a cool new antibody called 18H2 that helps scientists spot a key protein in immune cells that keep us healthy. This invention is ready for companies to license and turn into real products, speeding up research and treatments for autoimmune diseases. If you’re interested, now’s the time to reach out and get the details—money and timing depend on your licensing deal!
2026-10814 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and evaluate important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
Previous / Next Documents
Previous: 2026-11368 — Chromium Trioxide From India and Turkey; Scheduling of the Final Phase of Countervailing Duty and Antidumping Duty Investigations
The U.S. is taking a close look at imports of chromium trioxide from India and Turkey to see if they're hurting American businesses by being sold too cheaply or unfairly supported by the Indian government. This investigation could lead to extra taxes on these imports to protect U.S. industries. The final decision phase started on May 22, 2026, so changes might be coming soon for importers and buyers.
Next: 2026-11370 — Certain Clear Aligners and Components Thereof; Notice of a Commission Determination Not To Review an Initial Determination Granting In Part a Motion To Amend the Complaint and Notice of Investigation
The U.S. International Trade Commission decided to allow new claims in a patent dispute about clear aligners, like those used for teeth straightening. This affects companies involved in making or selling these aligners in the U.S., as more patent rights are now part of the investigation. The case started in late 2025, and this update means the investigation just got bigger, possibly impacting future sales and legal costs.